Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| SUNESIS PHARMACEUTICALS INC | 200,000 | reported | 12 Mar 2024 | tx 35+757,912−116,652 |
| Regulus Therapeutics Inc. | 77,870 | reported | 01 Jul 2019 | tx 12+886,359−15,922 |
| LENZ Therapeutics, Inc. | 12,886 | reported | 27 Mar 2026 | tx 8+381,530 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 Mar 2026 | PURCHASE | LENZ Therapeutics, Inc. | 7,500 | 8.57 USD | |
| 02 Jan 2026 | GRANT_AWARD | LENZ Therapeutics, Inc. | 14,000 | 0.00 USD | deriv |
| 02 Jan 2026 | GRANT_AWARD | LENZ Therapeutics, Inc. | 84,200 | 0.00 USD | deriv |
| 07 Nov 2025 | PURCHASE | LENZ Therapeutics, Inc. | 2,178 | 22.76 USD | first after silence |
| 07 Nov 2025 | PURCHASE | LENZ Therapeutics, Inc. | 20 | 22.71 USD | |
| 09 Jan 2025 | GRANT_AWARD | LENZ Therapeutics, Inc. | 70,444 | 0.00 USD | deriv |
| 14 May 2024 | PURCHASE | LENZ Therapeutics, Inc. | 3,188 | 15.68 USD | first after silence |
| 21 Mar 2024 | GRANT_AWARD | LENZ Therapeutics, Inc. | 200,000 | 0.00 USD | deriv |
| 12 Mar 2024 | GRANT_AWARD | SUNESIS PHARMACEUTICALS INC | 200,000 | 0.00 USD | deriv |
| 25 Feb 2024 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 6,889 | 0.00 USD | |
| 27 Feb 2024 | SALE | SUNESIS PHARMACEUTICALS INC | 3,405 | 0.73 USD | |
| 25 Feb 2024 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 6,889 | 0.00 USD | deriv |
| 28 Nov 2023 | SALE | SUNESIS PHARMACEUTICALS INC | 3,720 | 0.50 USD | |
| 25 Nov 2023 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 6,889 | 0.00 USD | |
| 25 Nov 2023 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 6,889 | 0.00 USD | deriv |
| 28 Aug 2023 | SALE | SUNESIS PHARMACEUTICALS INC | 3,512 | 1.45 USD | |
| 25 Aug 2023 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 6,888 | 0.00 USD | |
| 25 Aug 2023 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 6,888 | 0.00 USD | deriv |
| 25 May 2023 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 6,889 | 0.00 USD | |
| 25 May 2023 | SALE | SUNESIS PHARMACEUTICALS INC | 3,635 | 1.42 USD | |
| 25 May 2023 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 6,889 | 0.00 USD | deriv |
| 16 Mar 2023 | GRANT_AWARD | SUNESIS PHARMACEUTICALS INC | 200,000 | 0.00 USD | deriv |
| 27 Feb 2023 | SALE | SUNESIS PHARMACEUTICALS INC | 3,599 | 1.68 USD | |
| 25 Feb 2023 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 6,889 | 0.00 USD | |
| 25 Feb 2023 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 6,889 | 0.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 07 Nov 2025.